Physicians Stat Lab INC.
Physicians Stat Lab INC. was paid $99K by Medicaid between Jan 2018 and May 2024, across 67 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 26% of everything it billed.
CLERMONT, FL 34711
Next to other Clinical Medical Laboratory providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,454 | $310.09 | |
| 2019 | 25,028 | $265.69 | |
| 2020 | 32,556 | $30K | |
| 2021 | 34,249 | $28K | |
| 2022 | 23,455 | $15K | |
| 2023 | 15,527 | $23K | |
| 2024incomplete | 971 | $2K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 26% | 5,746 | 2,507 | $26K |
| 80053 | Comprehensive metabolic panel | 15% | 14,635 | 10,757 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 12% | 6,330 | 876 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 970 | 613 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.4% | 5,440 | 4,151 | $7K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 4.0% | 6,642 | 3,981 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.8% | 9,925 | 7,518 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 5,655 | 2,804 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.4% | 3,960 | 2,593 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.8% | 24 | 21 | $2K |
| 82607 | 1.6% | 5,459 | 4,164 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 17,591 | 12,312 | $2K |
55 more codes
| 80061 | Lipid panel | 1.5% | 9,892 | $1K |
| 87631 | 1.3% | 121 | $1K | |
| 87641 | 1.2% | 518 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.0% | 8,110 | $1K |
| 87799 | <1% | 291 | $960.85 | |
| 85610 | <1% | 2,972 | $762.28 | |
| 81001 | <1% | 5,799 | $643.96 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 693 | $641.47 |
| 87481 | <1% | 1,397 | $622.18 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,216 | $410.50 |
| 82746 | <1% | 1,699 | $386.10 | |
| 82728 | <1% | 1,461 | $381.78 | |
| 87542 | <1% | 290 | $329.22 | |
| 87653 | <1% | 648 | $298.76 | |
| 84479 | <1% | 407 | $275.19 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 4,859 | $268.49 |
| 87640 | <1% | 627 | $255.12 | |
| 84439 | <1% | 2,739 | $204.99 | |
| 84480 | <1% | 573 | $152.68 | |
| 83735 | <1% | 2,462 | $124.75 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,204 | $114.81 |
| 84436 | <1% | 1,139 | $95.29 | |
| 83540 | <1% | 1,978 | $69.91 | |
| 87500 | <1% | 478 | $63.44 | |
| 84481 | <1% | 80 | $29.47 | |
| 83550 | <1% | 748 | $28.54 | |
| 84146 | <1% | 13 | $14.27 | |
| 81002 | <1% | 15 | $3.48 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 1,306 | $2.68 |
| 87150 | 0% | 132 | $0.00 | |
| 82570 | 0% | 35 | $0.00 | |
| 82610 | 0% | 154 | $0.00 | |
| 80076 | 0% | 452 | $0.00 | |
| 80164 | 0% | 100 | $0.00 | |
| 87186 | 0% | 545 | $0.00 | |
| 87563 | 0% | 74 | $0.00 | |
| 84550 | 0% | 25 | $0.00 | |
| 86413 | 0% | 66 | $0.00 | |
| 82947 | 0% | 19 | $0.00 | |
| 82747 | 0% | 19 | $0.00 | |
| 84153 | 0% | 270 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 1,162 | $0.00 |
| 83880 | 0% | 167 | $0.00 | |
| 87505 | 0% | 43 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 177 | $0.00 |
| 82043 | 0% | 87 | $0.00 | |
| 87088 | 0% | 197 | $0.00 | |
| 87900 | 0% | 43 | $0.00 | |
| 87541 | 0% | 89 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 22 | $0.00 |
| 86140 | 0% | 49 | $0.00 | |
| 87077 | 0% | 35 | $0.00 | |
| 85651 | 0% | 55 | $0.00 | |
| 81000 | 0% | 45 | $0.00 | |
| 86409 | 0% | 66 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.